How much funding has Aclaris Therapeutics raised?

Aclaris Therapeutics has raised $122.0M in total funding, most recently a Private Equity round.

When was Aclaris Therapeutics founded?

Aclaris Therapeutics was founded in 2012.

Where is Aclaris Therapeutics headquartered?

Aclaris Therapeutics is headquartered in St. Louis, Missouri, United States.

What industry is Aclaris Therapeutics in?

Aclaris Therapeutics operates in Biotech, Healthcare.

How many employees does Aclaris Therapeutics have?

Aclaris Therapeutics has 11-50 employees.

Aclaris Therapeutics

Q: Who are Aclaris Therapeutics's investors?

Aclaris Therapeutics's investors include Vivo Capital, Fidelity Biosciences, Sofinnova Partners.

IPO

Home | Aclaris Therapeutics Inc.

Public · St. Louis, United States · Founded 2012 · $122.0M raised

Biotech

Healthcare

Headquarters: St. Louis, Missouri
Employees: 11–50
Founded: 2012
Business Model: B2B
Website: aclaristx.com

Total Funding: $122.0M
Last Round: $80.0M Private EquityJan 2020
Rounds: 3
Type: Public

About

Aclaris Therapeutics is a clinical-stage biopharmaceutical company developing novel drug candidates for immuno-inflammatory diseases.

Summary

Aclaris Therapeutics is a Biotech company based in St. Louis, United States, founded in 2012. It has raised $122.0M in total across 3 rounds, most recently a $80.0M Private Equity round in Jan 2020. Investors include Vivo Capital, Fidelity Biosciences and Sofinnova Partners.